Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Trodelvy
Trodelvy
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters
Fierce Pharma
Tue, 03/8/22 - 11:05 pm
Gilead Sciences
Immunomedics
Trodelvy
layoffs
Gilead says breast cancer drug succeeded in key study, but offers few details
BioPharma Dive
Mon, 03/7/22 - 10:52 pm
Gilead Sciences
Trodelvy
clinical trials
M&A
breast cancer
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
AstraZeneca
Daiichi Sankyo
Gilead Sciences
Trodelvy
triple negative breast cancer
Dato-DXd
Gilead, Merck to study combination therapy for breast cancer
Pharmaceutical Business Review
Fri, 10/29/21 - 10:56 am
Gilead Sciences
Merck
Trodelvy
Keytruda
triple negative breast cancer
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Big Pharma
cancer
oncology
Merck
Keytruda
AbbVie
Vraylar
Gilead Sciences
Trodelvy
Sanofi
Sarclisa
Novartis
ligelizumab
Gilead keeps pushing trove of Trodelvy data as it seeks to become new standard of care in TNBC
Endpoints
Thu, 09/16/21 - 10:42 am
ESMO
Gilead Sciences
Trodelvy
triple negative breast cancer
#ASCO21: Gilead's Trodelvy reads out new subgroup data showing benefit in earlier-line TNBC patients
Endpoints
Fri, 06/4/21 - 11:00 am
Gilead Sciences
Trodelvy
breast cancer
triple negative breast cancer
ASCO 2021
Gilead scores US approval for breast cancer drug that wowed ESMO
Pharmaforum
Thu, 04/8/21 - 10:23 am
Gilead Sciences
Trodelvy
FDA
ESMO
triple negative breast cancer
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst
Fierce Pharma
Thu, 09/24/20 - 11:26 pm
Gilead Sciences
Immunomedics
M&A
Trodelvy
ESMO
breast cancer
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
Beckers Hospital Review
Thu, 06/11/20 - 10:46 pm
OptumRx
Roche
PTC Therapeutics
risdiplam
SMA
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Immunomedics
Trodelvy
triple negative breast cancer
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Fierce Pharma
Mon, 05/11/20 - 11:35 pm
Immunomedics
drug launches
Trodelvy
triple-negative breast cancer
pandemic
COVID-19
FDA Approves Immunomedics' Breast Cancer Drug
Motley Fool
Wed, 04/22/20 - 10:43 pm
FDA
Immunomedics
triple negative breast cancer
Trodelvy
Pages
« first
‹ previous
1
2